The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors

Eberhard Blind*, Pieter A. de Graeff, Illiana Meurs, Frank Holtkamp, Ania Baczynska, Heidi Janssen

*Corresponding author for this work

    Research output: Contribution to journalEditorialAcademicpeer-review

    1 Citation (Scopus)
    Original languageEnglish
    Pages (from-to)502-503
    Number of pages2
    JournalEuropean Heart Journal
    Issue number6
    Publication statusPublished - 27-Dec-2015

    Cite this